Summary
While ACE inhibitors are considerably more expensive than thiazide diuretics, they are slightly more effective antihypertensive agents in white patients and have fewer side effects. They can be regarded as suitable first-line therapy in diabetic hypertensives. It is probable that as new drugs in this class are marketed, the price differential will lessen and they will be regarded as acceptable and useful first-line drugs in an increasingly large number of patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McMahon SW, Cutler JA, Furberg CD, et al. The effects of drug treatment for hypertension on mobility and mortality from cardiovascular disease: A review of randomised controlled trials.Prog Cardiovasc Dis 1986; (Suppl 1) 24:99–118.
Helgeland A, Strommen R, Hagelund C, et al. Enalapril, atenolol and hydrochlorothiazide in mild to moderate hypertension.Lancet 1986; 1:872–875.
Weinberger MH. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.Br J Clin Pharmacol 1982; 14:127S-131S.
Weinberger MH. Influence of an angiotensin converting enzyme inhibitor on diuretic-induced metabolic effects in hypertension.Hypertension 1983; (Suppl III) 00:132–138.
Merrill DD, Byymy RL, Carr A, et al. Lisinopril/HCTZ in essential hypertension (abstract).Clin Pharmacol Ther 1987; 41:227.
Pool JL, Gennari J, Goldstein R, et al. Controlled multicentre study of antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.J Cardiovasc Pharmacol 1987; 9 (Suppl 3):S36-S42.
Vidt DG. A controlled multiclinic study to compare the antihypertensive effects of MK-421 hydrochlorothiazide, and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension.J Hypertens 1984; 2 (Suppl 2):81–88.
Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Corea L, et al. Antihypertensive efficacy and tolerability of captopril in the elderly; comparison with hydrochlorothiazide and placebo in a multi-centre double-blind study.J Hypertens 1987; 5 (Suppl 5):S599-S602.
Shapiro DA, Liss CL, Walker JF, et al. Enalapril and hydrochlorothiazide as antihypertensive agents in the elderly.J Cardiovasc Pharmacol 1987; 00 (Suppl 7):S160-S162.
Zezulka AV, Gill JS, Dews I, et al. Comparison of enalapril and bendrofluazide for treatment of systemic hypertension.Am J Cardiol 1987; 59:630–633.
Frishman WH, Goldberger J, Sherman D. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.J Clin Hypertens 1987; 3:520–527.
Bauer JH, Jones LB. Comparative studies: Enalapril versus hydrochlorothiazide therapy as first-step therapy for the treatment of primary hypertension.Am J Kid Dis 1984; 4:55–62.
Freier PA, Wollam GL, Hall WD, et al. Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertension.Clin Pharmacol Ther 1984; 36:731–737.
Vlasses PH, Rotmensch HH, Swanson BN, et al. Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination.J Clin Pharmacol 1983; 23:227–233.
Woo J, Woo KS, To Kin, et al. A single-blind randomised cross-over study of angiotension-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.Arch Intern Med 1987; 147:1386–1389.
Kayanakis JG, Baulac L. The comparative study of oncedaily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension.Br J Clin Pharmacol 1987; 23:89S-92S.
Kochar MS, Bolek G, Kalbfleisch JH, et al. A 52 week comparison of lisinopril, hydrochlorothiazide and their combination in hypertension.J Clin Pharmacol 1987; 27:373–377.
Gums JG, Lopez MN, Quay GP, Stein GH, McCarley DL. Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension.Drug Intell Clin Pharm 1988; 22:680–684.
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life.N Engl J Med 1986; 314:1657–1664.
Medical Research Council Working Party. MRC trial of mild hypertension: Principal results.Br Med J 1985; 291:97–104.
Lasser NL, Grandits G, Caggiula AW, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.Am J Med 1984; 76(2A):52–66.
Freis ED. The cardiovascular risks of thiazide diuretics. Commentary.Clin Pharmacol Ther 1986; 39:239–244.
Varden S, Mehrotra KG, Mookherjee S, et al. Efficacy and reduced metabolic side-effects of 16 mg of chlorthalidone formulation in the treatment of mild hypertension.JAMA 1987; 252:484–488.
Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.Lancet 1985; 1:1349–1354.
Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.N Engl J Med 1983; 308:373–376.
Hommel E, Parying H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.Br Med J 1986; 293:467–470.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perry, I.J., Beevers, D.G. Ace inhibitors compared with thiazide diuretics as first-step antihypertensive therapy. Cardiovasc Drug Ther 3, 815–819 (1989). https://doi.org/10.1007/BF01869564
Issue Date:
DOI: https://doi.org/10.1007/BF01869564